scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1040566359 |
P356 | DOI | 10.1038/MODPATHOL.3800717 |
P698 | PubMed publication ID | 17115023 |
P50 | author | Luis Puig | Q42669207 |
P2093 | author name string | Carlos Ferrándiz | |
Aurelio Ariza | |||
Eva Musulén | |||
Enrique Lerma | |||
Sergio Serrano | |||
Montserrat Gilaberte | |||
María-Teresa Fernández-Figueras | |||
P2860 | cites work | Links between alpha-catenin, NF-kappaB, and squamous cell carcinoma in skin | Q24541453 |
Tissue inhibitors of metalloproteinases: evolution, structure and function | Q28138083 | ||
Merkel cell carcinoma: prognosis and treatment of patients from a single institution | Q28242597 | ||
CpG island methylation and expression of tumour-associated genes in lung carcinoma | Q30320221 | ||
Merkel-cell carcinoma of the skin | Q35909583 | ||
Matrix metalloproteinases as therapeutic targets in cancer | Q36126571 | ||
Merkel cells, normal and neoplastic: an update | Q36203819 | ||
Survivin, a cancer target with an emerging role in normal adult tissues | Q36491426 | ||
PPAR-gamma is expressed and NF-kB pathway is activated and correlates positively with COX-2 expression in stromal myofibroblasts surrounding colon adenocarcinomas | Q38440573 | ||
p38 regulates cyclooxygenase-2 in human mammary epithelial cells and is activated in premalignant tissue | Q38443641 | ||
Tissue micro-array: a cost and time-effective method for correlative studies by regional and national cancer study groups | Q38454152 | ||
Absence of classical MAP kinase pathway signalling in Merkel cell carcinoma | Q40312042 | ||
Essential role of p38gamma in K-Ras transformation independent of phosphorylation | Q40430785 | ||
Nuclear survivin is a powerful novel prognostic marker in gastroenteropancreatic neuroendocrine tumor disease | Q40432966 | ||
Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients. | Q40550067 | ||
Gene-expression profiling reveals distinct expression patterns for Classic versus Variant Merkel cell phenotypes and new classifier genes to distinguish Merkel cell from small-cell lung carcinoma | Q40593745 | ||
Expression and prognostic significance of matrix metalloproteinases and their tissue inhibitors in primary neuroendocrine carcinoma of the skin | Q40603566 | ||
Expression of bcl-6 protein in normal skin and epidermal neoplasms | Q41089601 | ||
Nuclear factor-kappaB dimer exchange promotes a p21(waf1/cip1) superinduction response in human T leukemic cells | Q42491580 | ||
Twenty-year follow-up study of long-term survival of limited-stage small-cell lung cancer and overview of prognostic and treatment factors | Q43418874 | ||
UV-B-type mutations and chromosomal imbalances indicate common pathways for the development of Merkel and skin squamous cell carcinomas | Q43981132 | ||
Merkel cell carcinoma: analysis of clinical, histologic, and immunohistologic features of 132 cases with relation to survival | Q44244548 | ||
c-kit expression in primary and metastatic merkel cell carcinoma | Q45201428 | ||
The 9 lives of beta-catenin | Q47369148 | ||
PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers | Q47720095 | ||
Validation of tissue microarray technology in ovarian carcinoma | Q47791732 | ||
Frequent allelic loss at 10q23 but low incidence of PTEN mutations in Merkel cell carcinoma. | Q49065989 | ||
Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma. | Q51674929 | ||
Neuroendocrine differentiation in extrahepatic bile duct carcinomas and its prognostic significance. | Q53355566 | ||
Cyclooxygenase-2 expression in primary Merkel cell carcinoma. | Q53361545 | ||
Immunohistochemical differential diagnosis between large cell neuroendocrine carcinoma and small cell carcinoma by tissue microarray analysis with a large antibody panel. | Q53622297 | ||
Optimization of antibodies for detection of the mismatch repair proteins MLH1, MSH2, MSH6, and PMS2 using a biotin-free visualization system. | Q54613560 | ||
A subset of high-grade pulmonary neuroendocrine carcinomas shows up-regulation of matrix metalloproteinase-7 associated with nuclear β-catenin immunoreactivity, independent of EGFR and HER-2 gene amplification or expression | Q56779554 | ||
Expression and Prognostic Significance of Metalloproteinases and Their Tissue Inhibitors in Patients With Small-Cell Lung Cancer | Q57272687 | ||
Expression of bcl-2 and p53 in Merkel cell carcinoma. An immunohistochemical study | Q71531368 | ||
CD44 expression in Merkel cell carcinoma may correlate with risk of metastasis | Q71624279 | ||
CD56: a useful marker for diagnosing Merkel cell carcinoma | Q73342835 | ||
Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinases TIMP-3 and -4 in benign endometrium and endometrial cancer | Q73507201 | ||
Expression of adhesion molecules and cytokeratin 20 in merkel cell carcinomas | Q80425901 | ||
The prognostic influence of neuroendocrine differentiation in breast cancer: results of a long-term follow-up study | Q80484346 | ||
TIMP-3 deficiency in the host, but not in the tumor, enhances tumor growth and angiogenesis | Q81267255 | ||
Neuroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy | Q81366824 | ||
Overexpression of hypoxia-inducible factor HIF-1alpha predicts early relapse in breast cancer: retrospective study in a series of 745 patients | Q81682235 | ||
Prognostic significance of p27Kip1, p45Skp2 and Ki67 expression profiles in Merkel cell carcinoma, extracutaneous small cell carcinoma, and cutaneous squamous cell carcinoma | Q81775303 | ||
Clinicopathological and immunohistochemical analysis of 20 cases of Merkel cell carcinoma in search of prognostic markers | Q81775306 | ||
The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma | Q81805558 | ||
Abnormal beta-catenin and reduced axin expression are associated with poor differentiation and progression in non-small cell lung cancer | Q83180916 | ||
Epidemiology of primary Merkel cell carcinoma in the United States | Q94325468 | ||
P433 | issue | 1 | |
P921 | main subject | Merkel cell carcinoma | Q1711744 |
P304 | page(s) | 90-101 | |
P577 | publication date | 2006-11-17 | |
P1433 | published in | Modern Pathology | Q15724578 |
P1476 | title | Expression profiles associated with aggressive behavior in Merkel cell carcinoma | |
P478 | volume | 20 |
Q34274250 | A Proteomic Study of Human Merkel Cell Carcinoma |
Q37550569 | Activation of PI3K signaling in Merkel cell carcinoma |
Q34170708 | Activation of the PI3K/AKT pathway in Merkel cell carcinoma |
Q36892143 | An unusual case of Merkel cell carcinoma |
Q48002445 | Clinical Implications of CD8+ T-cell infiltration in frequent and rare cancers |
Q35909855 | Detection of mitotic figures and G2+ tumor nuclei with histone markers correlates with worse overall survival in patients with Merkel cell carcinoma |
Q36684979 | Distinct gene expression profiles of viral- and nonviral-associated merkel cell carcinoma revealed by transcriptome analysis |
Q83553156 | Evidence for distinct populations of human Merkel cells |
Q39773470 | Expression of MMP-10, MMP-21, MMP-26, and MMP-28 in Merkel cell carcinoma |
Q64949324 | Histogenesis of Merkel Cell Carcinoma: A Comprehensive Review. |
Q34985137 | Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors. |
Q27001095 | Hypoxia-inducible factor 1 and its role in viral carcinogenesis |
Q34688574 | Increased expression of matrix metalloproteinases-21 and -26 and TIMP-4 in pancreatic adenocarcinoma |
Q38114084 | Merkel cell carcinoma of left groin: a case report and literature review. |
Q26796421 | Merkel cell carcinoma of the head and neck: pathogenesis, current and emerging treatment options |
Q38682926 | Merkel cell carcinoma: Do you know your guidelines? |
Q43239986 | Merkel cell carcinoma: chemotherapy and emerging new therapeutic options |
Q27021034 | Mutational analysis of merkel cell carcinoma |
Q46847155 | Silent mutations in KIT and PDGFRA and coexpression of receptors with SCF and PDGFA in Merkel cell carcinoma: implications for tyrosine kinase-based tumorigenesis |
Q41458291 | Systemic Therapy for Merkel Cell Carcinoma: What's on the Horizon? |
Q48239064 | Tumor vascularization and clinicopathologic parameters as prognostic factors in merkel cell carcinoma. |
Q41839134 | Vulvar merkel carcinoma: a case report |
Q85335650 | [Merkel cell carcinoma] |
Search more.